FDA authorizes Moderna and Johnson & Johnson COVID-19 booster shots

Print Friendly, PDF & Email

WASHINGTON — The FDA has authorized booster doses of both COVID-19 vaccines made by Moderna and Johnson & Johnson Wednesday and also said any of the three authorized vaccines could be used as a booster in a “mix and match” approach.

The FDA gave emergency use authorization for a half dose of Moderna’s vaccine as a booster for people fully vaccinated at least six months ago who are also at least 65, or who are at least 18 and who are at high risk of severe COVID-19 or have frequent institutional or occupational exposure to SARS-CoV-2.

It also authorized booster doses of Johnson & Johnson’s vaccine.

“The use of a single booster dose of the Janssen (Johnson and Johnson) COVID-19 Vaccine may be administered at least 2 months after completion of the single-dose primary regimen to individuals 18 years of age and older,” the FDA said in a statement.




Comments are closed.